Background. Mortality risk tends to be higher among elderly individuals with higher serum adiponectin levels. The objective of this study was to clarify whether the relationship between adiponectin and a higher risk of disability or death can be explained by physical function, bone mineral density, depression, and malnutrition.
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A LTHOUGH adiponectin is a protein that is derived predominantly from adipose tissue (1, 2) , levels are paradoxically inversely associated with obesity. Laboratory studies have shown that adiponectin is antiatherogenic (3) . Whereas the findings of several studies have associated higher adiponectin levels with a lower risk of cardiovascular disease (CVD) and mortality (4, 5, 6) , the results of a meta-analysis suggest that the relationship between adiponectin and CVD is not as close as was previously thought (7) . Furthermore, studies that have focused on elderly individuals have also generated contradictory findings (8, 9, 10) , having consistently demonstrated a positive association between adiponectin and CVD or all-cause mortality.
Physical function (11) , bone mineral density (12) , depression (13) , and malnutrition (14) are associated with premature death or disability among elderly individuals. Adiponectin levels that are inversely associated with obesity might be associated with these risk factors. In addition, an experimental study of transgenic mice suggested that circulating adiponectin plays a negative role in the acquisition of bone during growth (15) . Therefore, these factors must be taken into consideration when investigating relationships between adiponectin and health outcomes among elderly individuals. Recent studies also suggest that higher mortality rates in individuals with higher adiponectin levels can be explained by the contribution of N-terminal pro-B-type natriuretic peptide (NT-pro-BNP; 2,16). Natriuretic peptide is a marker of cardiac dysfunction that enhances adiponectin production by human adipocytes in vitro, and adiponectin levels are in fact increased in patients with chronic heart Relationship Between Serum Adiponectin Levels and Disability-Free Survival Among Community-Dwelling Elderly Individuals: The Tsurugaya Project failure and cardiac dysfunction (17) . This also suggests that NT-pro-BNP plays an important role in the relationship between adiponectin and mortality or death. The Tsurugaya Project estimated not only the CVD risk profile but also the physical function, depressive symptoms, nutritional status, and NT-pro-BNP levels. This study aimed to determine whether physical function, bone mineral density, depression, malnutrition, and a higher NT-pro-BNP level can explain the relationship between adiponectin and increased risk of disability or death.
Methods

Study Participants
The Tsurugaya Project was a comprehensive geriatric assessment (CGA) implemented in 2002 and 2003 that included medical status as well as physical and cognitive functions (18, 19, 20, 21) . The present study is based on the data from 2002 because stored blood samples from that time period were available (21).
Among 2,730 inhabitants aged 70 years or more living in the Tsurugaya area of Sendai, Japan, 1,177 provided written informed consent to participate in the study. Because we did not obtain agreement to review information regarding longterm care insurance (LTCI) in 2002, we requested agreement to do so from participants who underwent CGA in 2003. Of the 1,177 participants who underwent CGA in 2002, 671 underwent another CGA in 2003 and 657 agreed to a review of their LTCI information. Among these 657 participants, we excluded those who had already been certified as having a disability determined by LTCI certification by 2003 (n = 55), did not agree to their blood samples being analyzed or stored (n = 6), or whose serum samples were of insufficient volume to measure adiponectin (n = 91). Thus, the present study analyzed data from 505 participants.
A comparison of the 657 individuals who agreed to a review of their LTCI information and 520 who did not participate in the 2003 survey or who did not agree to a review of their LTCI information showed that the mean age of the former group was lower (75.6 vs 76.8 years; p < .01) and the proportion of women was lower (54.9% vs 63.1%; p < .01).
The Ethics Committee of Tohoku University Graduate School of Medicine approved the study protocol.
Serum Adiponectin and NT-pro-BNP
Blood samples collected under nonfasting conditions were immediately cooled at 4°C, centrifuged within 4 hours at 3,000g at 4°C for 10 minutes, and stored at −80°C. Levels of adiponectin were measured using an enzyme-linked immunosorbent assay or a latex particle-enhanced turbidimetric immunoassay. The values of adiponectin determined by enzyme-linked immunosorbent assay and by latex particleenhanced turbidimetric immunoassay are closely correlated (r = .98). Others have reported a similarly close correlation (22) . Levels of NT-pro-BNP were measured using an electrochemiluminescence immunoassay kit (MODULAR AN-ALYTICS E10; Roche Diagnostics, Penzberg, Germany; 21). All the above assays proceeded at a clinical testing laboratory (SRL, Tokyo, Japan).
Other Measurements
Information about smoking status, alcohol consumption, history of disease, and physical activity was surveyed using a questionnaire, and drug information was confirmed by an experienced pharmacist. Symptoms of depression were assessed based on the Japanese version of the 30-item geriatric depression scale (19) . Functional reach, which measures how far an individual can reach forward beyond arm's length while standing without losing balance, was measured as a parameter of physical function (20) . We measured quantitative ultrasound parameters, such as the speed of sound (meters/second), broadband ultrasound attenuation (decibels/megahertz), and the stiffness index (Stiffness), which was derived from the speed of sound and broadband ultrasound attenuation. These parameters were measured in the right calcaneus using an Achilles Ultrasound Bone Densitometer (A-1000; GE-Lunar Corporation, Madison, WI; 23). Self-measured blood pressure at home was measured using an automated device (HEM747IC; Omron Life Science Co. Ltd, Tokyo, Japan; 18). The participants were classified into groups based on those with home hypertension, home borderline hypertension, and home normotension according to the guidelines for home blood pressure (24) . Participants prescribed with antihypertensive medication were classified into the home hypertension group. Serum albumin, total cholesterol, triglyceride, high-density lipoprotein cholesterol, and glucose levels were also measured. Glomerular filtration ratios were estimated using a modified equation for Japanese individuals based on the abbreviated Modification of Diet in Renal Disease study (25) .
LTCI Certification
We defined incident disability as assessed by the LTCI certification system that was launched as the national insurance scheme during April 2000 (26, 27, 28) and followed up those with certified incident disability for 6 years.
Individuals living in Japan aged 40-64 years who are diagnosed with aging-related diseases (eg, Alzheimer's disease and stroke) and those aged 65 years or more who are certified as requiring care are eligible for benefits based on the level of care under the LTCI certification (29) . To receive LTCI services, elderly individuals or their caregivers (family or professional) must contact the municipal government to have their care needs officially certified (27) . A trained local government official visits their homes to evaluate nursing care needs using a questionnaire that assesses their current physical and mental status and use of medical procedures (26) . Standardized scores for physical and mental functions and the estimated amount of time required for care for nine categories (grooming/bathing, eating, using the toilet, transferring, eating, assistance with instrumental activities of daily living, behavioral problems, rehabilitation, and medical services) are then calculated using software. Based on national values, a decision is reached as to whether applicants should be certified to receive LTCI services, and the system assigns a care needs level determined by a certification board comprising physician nurses and other experts in health and social services appointed by the local mayor.
Care needs are assessed in seven levels that closely correlate with the Barthel Index (Spearman's coefficient: −.86) and the Mini-Mental State Examination (Spearman's coefficient: −.42; 29, 30) . The definition can be considered as a comprehensive measure of disability among elderly individuals (30) .
Sendai City Municipal Authority provided annual information about LTCI certification including care level, date of certification, moving, and death for the 6 years between June 30, 2003 , and June 30, 2009. We defined incident disability as certification at any level of care need and the first date of certification as the date of incident disability occurrence. Only six individuals were lost due to moving during follow-up. We used a composite outcome of disability and death, which can be considered as an indicator of disability-free survival.
Statistical Analysis
We classified the study participants into five groups based on an adiponectin distribution of 8, 11, 16, and 22.4 mg/L using 25%, 50%, 75%, and 90%, respectively, as cutoff points. To distinguish the characteristics of a group with higher adiponectin levels, we added a 90% cutoff in addition to the traditional quartiles because serum adiponectin levels were skewed. This approach has been applied in several epidemiological studies in which values were skewed (31) .
Baseline characteristics were compared using the c 2 test and analysis of variance as appropriate. We assessed the proportionality assumption by examining changes in risk factor effects with time and by examining the possibility that risk factor effects could be different risk factor strata. The results of these analyses indicated that the proportionality assumption was appropriate. The Hazard ratio and 95% confidence interval for the relationship between adiponectin and the composite outcome of incident disability or mortality were calculated using the following Cox proportional hazards models. Model 1 was adjusted for age, sex, smoking, alcohol consumption (<23, 23-45.9, and ≥46 g of ethanol/day), and factors related to metabolic syndrome, namely, blood pressure category (home hypertension, home borderline hypertension, and home normotension), blood glucose category (diabetes: nonfasting blood glucose ≥200 mg/dL [11.1 mmol/L] or taking antidiabetic drugs; impaired blood glucose as nonfasting blood glucose 140-199 mg/dL [7.7-11 .0 mmol/L]), triglycerides, high-density lipoprotein cholesterol, quintiles of body mass index, and a history of CVD. Model 2 was adjusted for Model 1 plus NT-pro-BNP using 49, 81, 137, and 250 pg/mL as cutoffs (25th, 50th, 75th, and 90th percentiles). Participants without NT-pro-BNP data were categorized into a "missing data" category (N = 44). Model 
We also analyzed the relationship between serum adiponectin and the composite outcome of incident disability or mortality excluding participants with a history of CVD using Model 1.
The level of statistical significance was set at p < .05. All data were statistically analyzed using SAS software, version 9.1 (SAS Institute, Cary, NC). Table 1 shows the baseline characteristics according to adiponectin categories. Mean age was higher in the categories with higher adiponectin values. Higher adiponectin values were associated with larger proportions of women and those who had never smoked, were underweight, and had a lower functional reach, depressive symptoms, less stiffness, and higher NT-pro-BNP values. Conversely, lower values for factors related to metabolic syndrome (hypertension, diabetes, triglycerides, high-density lipoprotein cholesterol, and obesity) and fewer participants with a history of CVD were associated with higher adiponectin values.
Results
Of 179 individuals who developed incident disability or died during the 6 years of follow-up, 20 and 23 died with and without LTCI certification, respectively, and 136 (76%) were certificated as LTCI only. The rate of incident disability or deaths was lower and higher in the categories with decreased and elevated adiponectin values, respectively (<25th and ≥90th percentiles: 45.4/1,000 and 138.0/1,000 person-years, respectively; Table 2 ). This relationship was also evident in the model adjusted for age, sex, smoking, and factors related to metabolic syndrome (Model 1). This positive relationship persisted when participants with a history of CVD were excluded (data not shown). The Hazard ratio for the comparison of the highest and lowest adiponectin categories did not materially change after adjustment for NT-pro-BNP, malnutrition and depressive symptoms, or estimated glomerular filtration rate (Models 2-4). In contrast, adjustment for physical function and bone mineral density attenuated the positive relationship between adiponectin and the composite outcome of disability. In turn, the positive relationship disappeared when participants who moved (N = 4), died, or were certified as having incident disability (N = 88) within 3 years of follow-up were excluded. Model 6 comprised 413 participants and 91 died or were certified as having a disability by the end of follow-up. The fully adjusted model that included participants who moved, died, or were certified as having a disability within 3 years of follow-up (Model 7) revealed the same modest association as Model 5. In the fully adjusted model that excluded participants who died or were certified as having a disability within 3 years of follow-up (Model 8), the positive relationship between serum adiponectin and the composite outcome of disability and death disappeared altogether. Notes: Cutoff of adiponectin value was defined as 25%, 50%, 75%, and 90%; home HT = home systolic BP ≥135 mm Hg and/or home diastolic BP ≥85 mm Hg and/or user of antihypertensive medication; home BHT = not satisfied with home HT criteria and home systolic BP ≥125 mm Hg and/or home diastolic BP ≥80 mm Hg; home NT = home systolic BP <125 mm Hg and home diastolic BP <80 mm Hg without antihypertensive medication; diabetes= user of antidiabetic drug or nonfasting blood glucose ≥200 mg/dL (11.1 mmol/L); impaired blood glucose = nonfasting blood glucose 140-199 mg/dL (7.7-11.0 mmol/L); overweight/obesity = body mass index ≥25 kg/m 2 ; underweight = body mass index <18.5 kg/m 2 ; low albumin = albumin ≤3.8 g/dL; depression = user of antidepressant or geriatric depression scale ≥11 points; chronic kidney disease= glomerular filtration ratio ≤ 60 mL/min/1.73 m 2 ; BHT = borderline hypertensive; BP = blood pressure; CVD = cardiovascular diseases; HT = hypertensive; NT = normotensive.
Discussion
The present study clarified that the positive relationship between adiponectin and the composite outcome of disability and death was attenuated by adjusting for physical function or excluding early events. Therefore, assessing physical function and subclinical wasting might be required to assess participants with higher adiponectin levels.
The advantages of the present study are as follows. We assessed comprehensive geriatric parameters including physical function and depressive symptoms. Furthermore, whether the contribution of high BNP could help to explain the relationship between serum adiponectin and disabilityfree survival in this population was determined based on NT-pro-BNP values. The LTCI certification is based upon strictly established, uniform rules throughout Japan (26, 27) , and the included information enabled a very high follow-up rate in the present study (98.8%). Nevertheless, this system is not perfect because elderly individuals or caregivers must initiate contact with the municipal government to receive LTCI services, and thus, some elderly individuals with a disability might not be certified. Another issue is the date of incident disability. Although we used the date for LTCI certification as date of incident disability, the actual date would normally be earlier than that date certified as LTCI. Other methodological limitations are also associated with the study. Because we did not obtain the agreement of participants to review their LTCI information in 2002, we analyzed 60% of those who had a CGA at 2002. Participants who agreed to such review were younger than those who did not participate in the 2003 survey or who refused to permit disclosure of their LTCI information. We also excluded those who already had a disability according to LTCI certification at 2003. Therefore, the prevalence of a higher serum adiponectin value in this study might not accurately represent the prevalence in this area. Nevertheless, we considered that the relationship between adiponectin and incident disability and mortality was clarified. Another limitation was that the lack of information about the causes of disability, which obstructed clarification as to whether the frequency of incident disability due to stroke, mobility restriction, or other reasons was higher in the group with higher serum adiponectin values. Finally, we did not obtain fasting blood samples, and thus, the accuracy of diabetes-related assessments or of total cholesterol might be limited in this study.
Several mechanisms could explain the positive relationship between adiponectin and disability or death. The present study showed that adjustment for physical function and bone mineral density largely attenuated the relationship. A recent study found an inverse association between adiponectin and muscular fitness (32), and our cross-sectional findings revealed an inverse association between physical function and adiponectin. Furthermore, the Cardiovascular Health Study All Stars Study showed that adiponectin was associated with a greater physical decline (33) . Thus, older participants with higher adiponectin might have lower physical function as well as less body fat. A similarly inverse association between adiponectin and bone mineral density has also been reported (34) . Because adjusting for physical function and bone mineral density attenuates the relationship between adiponectin and disability or death, lower physical function and lower bone mineral density in individuals with higher adiponectin may play important role in the relationship between adiponectin and disability or death. However, our finding, that is, relatively strong effect of physical activity and bone mineral density on the relationship between adiponectin and composite endpoint, might be due to the outcome consisting predominantly of physical disability (76% of events). Further studies might be required to confirm whether physical function attenuates the relationship between adiponectin and mortality. Another possible candidate mechanism is the effect of NT-pro-BNP on the relationship between adiponectin and mortality. Although Wannamethee and colleagues and Kirstop and colleagues indicated that adjusting for NT-pro-BNP largely attenuates the relationship between adiponectin and mortality (2, 19) , such adjustment in the present study did not attenuate the relationship between adiponectin and disability or death. The contribution of NT-pro-BNP to the relationship between adiponectin and disability or death might be smaller in our Japanese cohort than in previous reports. Further studies are required to confirm our findings. The present study also clarified that the contribution of renal function or malnutrition to the relationship between adiponectin and disability or death was small. We did not find any positive associations between adiponectin and disability or death after excluding early death or disability that occurred within 3 years. Despite the limited statistical power of this approach, the findings nevertheless suggest that elderly individuals with higher adiponectin levels are likely to develop or already have wasting conditions that are associated with early disability or death. Thus, physical function and subclinical conditions should be assessed among older participants with higher adiponectin levels.
In conclusion, we found that circulating adiponectin levels are positively associated with disability or death. This association was weakened when we adjusted for physical function and excluded early events. Therefore, the positive relationship between higher adiponectin levels and disability or death might be partly explained by lower physical function and physical wasting. 
